Technology ❯ Biotechnology

mRNA Technology

Vaccine Development Vaccine Technology Therapeutics Vaccine Production Drug Development Research and Development Vaccine Innovation Cancer Research Drug Delivery Systems Innovations Therapeutic Development Vaccines Personalized Medicine Pharmaceutical Technology Lipid Nanoparticles Cancer Therapy Cancer Vaccines Artificial Intelligence Vaccine Delivery mRNA-1083 Vaccine Delivery Systems Lipid Nanoparticle Delivery Clinical Trials

BioNTech Founders to Exit This Year to Launch New mRNA Company as Stock Slumps on Weak Outlook

A weak outlook alongside a quarterly loss sent shares tumbling, prompting a board-led search for new leadership.

Moderna Reaches Up to $2.25 Billion LNP Patent Settlement, Pays $950 Million Upfront

FDA to Review Moderna’s Flu Shot as Shares Rally on Earnings Beat

Moderna, Merck Melanoma Vaccine Shows Durable Five-Year Benefit as Stock Hits 52-Week High

CEPI Puts Up to $54.3 Million Behind Moderna’s H5 mRNA Bird Flu Vaccine for Phase 3

Moderna Scraps CMV Vaccine Program After Phase 3 Failure

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

US Cuts $500 Million in mRNA Vaccine Research Funding

Membrane-Bound mRNA HIV Vaccine Elicits Neutralizing Antibodies in 80% of Participants

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Trial

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy